Medicare Enrolled

Curtis Nyarko, PA-C

Physician Assistant · Miami Shores, FL
9111 PARK DR, Miami Shores, FL 33138
3057566110
Registered in NPPES since 2021
NPI: 1871186148 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Nyarko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Nyarko? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Nyarko

Curtis Nyarko is a physician assistant in Miami Shores, FL, with 5 years of NPI registration.

Between the years covered by Open Payments, Nyarko received a total of $3,063 from 29 pharmaceutical and/or device companies across 142 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Nyarko is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years of NPI registration $3,063 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,063
Total received (2023-2024)
Avg $1,531/year across 2 years
Top 15% in FL for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
142
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,915
2023
$1,148

Payments by company (2024)

ABBVIE INC.
$309
Boehringer Ingelheim Pharmaceuticals, Inc.
$186
AstraZeneca Pharmaceuticals LP
$178
ViiV Healthcare Company
$175
Amgen Inc.
$137
GlaxoSmithKline, LLC.
$114
Exact Sciences Corporation
$105
Bayer Healthcare Pharmaceuticals Inc.
$101
Lilly USA, LLC
$99
Novo Nordisk Inc
$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
PFIZER INC.
$55
Janssen Pharmaceuticals, Inc
$40
HARMONY BIOSCIENCES LLC
$37
AIMMUNE THERAPEUTICS, INC.
$32
Gilead Sciences, Inc.
$31
Dexcom, Inc.
$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Phadia US Inc.
$21
Abbott Laboratories
$20
SHIELD THERAPEUTICS INC
$19
Esperion Therapeutics, Inc.
$18
Verity Pharmaceuticals Inc.
$18
IBSA Pharma Inc.
$17
Antares Pharma, Inc.
$16
Top 3 companies account for 35.1% of 2024 payments
All-time payments by company (2023-2024) ›
ABBVIE INC.
$535
AstraZeneca Pharmaceuticals LP
$499
Boehringer Ingelheim Pharmaceuticals, Inc.
$259
Lilly USA, LLC
$186
Exact Sciences Corporation
$177
ViiV Healthcare Company
$175
GlaxoSmithKline, LLC.
$171
Bayer Healthcare Pharmaceuticals Inc.
$165
Amgen Inc.
$161
Novo Nordisk Inc
$125
PFIZER INC.
$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
Janssen Pharmaceuticals, Inc
$40
Abbott Laboratories
$40
HARMONY BIOSCIENCES LLC
$37
GENZYME CORPORATION
$32
AIMMUNE THERAPEUTICS, INC.
$32
Gilead Sciences, Inc.
$31
Supernus Pharmaceuticals, Inc.
$29
Dexcom, Inc.
$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
IDORSIA PHARMACEUTICALS US INC
$24
Phadia US Inc.
$21
SHIELD THERAPEUTICS INC
$19
Amarin Pharma Inc.
$18
Esperion Therapeutics, Inc.
$18
Verity Pharmaceuticals Inc.
$18
IBSA Pharma Inc.
$17
Antares Pharma, Inc.
$16
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANDEXXA · APRETUDE · AREXVY · BREZTRI · CAPLYTA · COMIRNATY · CREON · Cologuard Collection Kit · DUPIXENT · Dexcom G6 Transmitter · ELIQUIS · EUCRISA · EVENITY · FARXIGA · FREESTYLE LIBRE · ImmunoCAP · JARDIANCE · Kerendia · LINZESS · MOUNJARO · NEXLETOL · Otezla · Ozempic · PAXLOVID · QULIPTA · QUVIVIQ · Rybelsus · SHINGRIX · TRADJENTA · TRELEGY ELLIPTA · Tirosint · Tlando · UBRELVY · VRAYLAR · Vascepa · WAKIX · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZENPEP · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a physician assistant in Miami Shores?
Compare physician assistants in the Miami Shores area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants in nearby ZIP areas
1,644
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
NORTH SHORE MEDICAL CENTER
1.8 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Nyarko is a physician assistant.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Nyarko receive payments from pharmaceutical companies?
Yes. Nyarko received a total of $3,063 from 29 companies across 142 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Nyarko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Physician Assistants in Miami Shores
Browse physician assistants in Miami Shores ranked by procedure volume and transparency data.
Highest volume
Top Physician Assistants in FL
Physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physician Assistants in FL
Which FL physician assistants receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →